Literature DB >> 15161749

Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time.

Anna Moore1, Jan Grimm, Bingye Han, Pere Santamaria.   

Abstract

Development of autoimmune diabetes in both humans and mice is preceded by a prolonged period of inflammation of pancreatic islets by autoreactive T-cells. Noninvasive imaging techniques, including positron-emission tomography and optical or magnetic resonance imaging, have been used to track the recruitment of lymphocytes to sites of inflammation. These techniques, however, rely on labeling strategies that are non-antigen specific and do not allow specific tracking of the recruitment of autoreactive lymphocytes. Here we describe an antigen-specific magnetic label to selectively target a prevalent population of diabetogenic CD8(+) T-cells that contribute to the progression of insulitis to overt diabetes in NOD mice. Superparamagnetic nanoparticles coated with multiple copies of a high-avidity peptide/major histocompatibility complex ligand of these T-cells (NRP-V7/K(d)) are endocytosed by CD8(+) T-cells in an antigen-specific manner. Using these T-cells as probes, we show that inflammation of pancreatic islets by autoreactive T-cells can be detected in real time by magnetic resonance imaging. This study demonstrates the feasibility of visualizing the presence of ongoing autoimmune responses noninvasively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161749     DOI: 10.2337/diabetes.53.6.1459

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes.

Authors:  Stuart E Turvey; Eric Swart; Maria C Denis; Umar Mahmood; Christophe Benoist; Ralph Weissleder; Diane Mathis
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 2.  Imaging stem cells implanted in infarcted myocardium.

Authors:  Rong Zhou; Paul D Acton; Victor A Ferrari
Journal:  J Am Coll Cardiol       Date:  2006-11-01       Impact factor: 24.094

3.  High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner.

Authors:  Z Zhang; E J van den Bos; P A Wielopolski; M de Jong-Popijus; D J Duncker; G P Krestin
Journal:  MAGMA       Date:  2004-10-28       Impact factor: 2.310

Review 4.  Magnetic resonance molecular imaging with nanoparticles.

Authors:  Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Katherine C Crowder; Samuel A Wickline
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

5.  Current status of imaging pancreatic islets.

Authors:  John Virostko; Eric Duco Jansen; Alvin C Powers
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 6.  [Cell tracking. Principles and applications].

Authors:  J Grimm; M F Kircher; R Weissleder
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

7.  In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.

Authors:  Heike E Daldrup-Link; Reinhardt Meier; Martina Rudelius; Guido Piontek; Morand Piert; Stephan Metz; Marcus Settles; Christoph Uherek; Winfried Wels; Jürgen Schlegel; Ernst J Rummeny
Journal:  Eur Radiol       Date:  2004-12-23       Impact factor: 5.315

Review 8.  Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization.

Authors:  Jonathan R Slotkin; Kevin S Cahill; Suzanne A Tharin; Erik M Shapiro
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

9.  Designing inorganic nanomaterials for vaccines and immunotherapies.

Authors:  Krystina L Hess; Igor L Medintz; Christopher M Jewell
Journal:  Nano Today       Date:  2019-05-29       Impact factor: 20.722

Review 10.  Biomarkers in type 1 diabetes: application to the clinical trial setting.

Authors:  James E Tooley; Kevan C Herold
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.